Evolent Health, Inc.

EVH

US30050B1017

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 12:03:21 2024-05-13 pm EDT			5-day change	1st Jan Change
24.17 ^USD	-1.19%		-11.14%	-26.72%

May. 10	UBS Trims Price Target on Evolent Health to $44 From $46, Keeps Buy Rating	MT
May. 09	Evolent Health Q1 Adjusted Earnings, Revenue Rise; Q2 Revenue Guidance Set, 2024 Revenue Outlook Increased	MT

Evolent Health, Inc. Provides Earnings Guidance for the Fourth Quarter of 2021

November 03, 2021 at 04:02 pm EDT

Evolent Health, Inc. provided earnings guidance for the fourth quarter of 2021. For the quarter, the company expects revenue to be in the range of approximately $225 million to $240 million.

Latest news about Evolent Health, Inc.

UBS Trims Price Target on Evolent Health to $44 From $46, Keeps Buy Rating	May. 10	MT
Evolent Health Q1 Adjusted Earnings, Revenue Rise; Q2 Revenue Guidance Set, 2024 Revenue Outlook Increased	May. 09	MT
Transcript : Evolent Health, Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
Earnings Flash (EVH) EVOLENT HEALTH Posts Q1 EPS $0.34, vs. Street Est of $0.30	May. 09	MT
Earnings Flash (EVH) EVOLENT HEALTH Posts Q1 Revenue $639.7M, vs. Street Est of $598.9M	May. 09	MT
Evolent Health, Inc. and Careology Form Strategic Care Navigation Partnership to Enhance Cancer Care in the U.S	May. 09	CI
Evolent Health, Inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2024 and Raises Earnings Guidance for the Full Year Full Year Ending December 31, 2024	May. 09	CI
Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target	Apr. 22	MT
Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating	Mar. 28	MT
JPMorgan Trims Price Target on Evolent Health to $52 From $53, Maintains Overweight Rating	Mar. 15	MT
Transcript : Evolent Health, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 02:35 PM	Mar. 12
Canaccord Genuity Cuts Price Target on Evolent Health to $45 From $47, Maintains Buy Rating	Feb. 23	MT
Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours	Feb. 22	MT
Transcript : Evolent Health, Inc., Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 EPS $0.23, vs. Street Est of $0.15	Feb. 22	MT
Earnings Flash (EVH) EVOLENT HEALTH Posts Q4 Revenue $556.1M, vs. Street Est of $542.9M	Feb. 22	MT
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	Feb. 22	CI
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
Evolent Health, Inc. Announces Board Changes	Feb. 14	CI
Transcript : Evolent Health, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 03:45 PM	Jan. 09
JMP Securities Initiates Evolent Health With Market Outperform Rating, Price Target is $37	Dec. 06	MT
Evolent Health Plans $350 Million Convertible Senior Notes Offering; Shares Fall	Dec. 05	MT
Evolent Health Shares Drop on $350 Million Note Offering	Dec. 05	DJ
RBC Trims Price Target on Evolent Health to $42 From $44, Keeps Outperform Rating	Nov. 28	MT
Truist Securities Trims Price Target on Evolent Health to $34 From $36, Maintains Hold Rating	Nov. 14	MT

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-15 - RBC Capital Markets Global Healthcare Conference

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Evolent Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

24.46 USD

Average target price

43.29 USD

Spread / Average Target

+76.97%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

	1st Jan change	Capi.
EVOLENT HEALTH, INC.	-26.72%	2.8B
VEEVA SYSTEMS INC.	+6.03%	32.93B
PRO MEDICUS LIMITED	+18.24%	7.94B
SECTRA AB	+30.15%	4.19B
OMNICELL, INC.	-17.51%	1.38B
LUNIT INC.	-33.33%	1.17B
SIMULATIONS PLUS, INC.	+9.84%	966M
B-SOFT CO.,LTD.	-37.56%	900M
VERADIGM INC.	-26.60%	839M
SURGICAL SCIENCE SWEDEN AB	-19.89%	687M

Medical Software & Technology Services